MCID: PLM035
MIFTS: 46

Pulmonary Eosinophilia malady

Categories: Respiratory diseases, Blood diseases

Aliases & Classifications for Pulmonary Eosinophilia

About this section

Aliases & Descriptions for Pulmonary Eosinophilia:

Name: Pulmonary Eosinophilia 11 50 13 68
 
Asthmatic Pulmonary Eosinophilia 68

Classifications:



External Ids:

Disease Ontology11 DOID:9498
ICD9CM32 518.3
MeSH39 D011657
ICD1030 J82

Summaries for Pulmonary Eosinophilia

About this section
MalaCards based summary: Pulmonary Eosinophilia, also known as asthmatic pulmonary eosinophilia, is related to pulmonary tuberculosis and loeffler syndrome. An important gene associated with Pulmonary Eosinophilia is IL5 (Interleukin 5), and among its related pathways are Inflammatory Response Pathway and OX40 Pathway. Affiliated tissues include lung, t cells and testes, and related mouse phenotypes are respiratory system and hematopoietic system.

Related Diseases for Pulmonary Eosinophilia

About this section

Diseases related to Pulmonary Eosinophilia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 153)
idRelated DiseaseScoreTop Affiliating Genes
1pulmonary tuberculosis28.8CCL11, CCL5, IL13, IL4, IL5, RNASE3
2loeffler syndrome11.7
3eosinophilic pneumonia11.5
4chronic eosinophilic pneumonia11.4
5idiopathic acute eosinophilic pneumonia11.2
6restrictive cardiomyopathy10.3IL5, RNASE3
7peptidic growth factors deficiency10.3CCL11, IL5
8natural killer cell leukemia10.3CCL11, IL5
9brown shrimp allergy10.3IL5, RNASE3
10dahlberg borer newcomer syndrome10.2IL13, IL5
11hidradenitis suppurativa10.2CCL11, CCL5
12vulvar disease10.2CCL5, RNASE3
13papillary squamous carcinoma10.2IL4, IL5
14benign meningioma10.2IL5, RNASE3
15aortic atherosclerosis10.2IL13, IL5
16psychotic disorder10.2CCL11, IL4
17hypersensitivity vasculitis10.2IL4, IL5
18allescheriosis10.2IL4, IL5
19retinal vascular disease10.2CCL11, IL4
20urethral intrinsic sphincter deficiency10.2IL4, IL5
21israeli tick typhus10.2CCL5, IL13
22amelogenesis imperfecta 1j10.2EPX, RNASE3
23breast intracanalicular fibroadenoma10.2IL4, IL5
24isthmus cancer10.2CCL11, IL4
25middle lobe syndrome10.2CCL17, IL5
26choledochal cyst10.2CSF2, IL5
27crustacean allergy10.2IL13, IL4
28histoplasmosis retinitis10.2IL4, IL5
29familial renal papillary carcinoma10.2CCL11, IL5, RNASE3
30goat milk allergy10.2IL13, IL4
31monocytic leukemia10.2CCL11, IL5, RNASE3
32osteodysplasty precocious of danks mayne and kozlowski10.1CCL5, IL4
33marasmus10.1IL4, IL5, RNASE3
34appendix carcinoid tumor10.1EPX, RNASE3
35lens-induced iridocyclitis10.1IL4, IL5, RNASE3
36multiple epiphyseal dysplasia due to collagen 9 anomaly10.1IL4, IL5, RNASE3
37orbit alveolar rhabdomyosarcoma10.1IL4, IL5, RNASE3
38anterior dislocation of lens10.1CCL11, IL4, RNASE3
39small intestine lymphoma10.1IL5, RNASE3
40chemical colitis10.1EPX, RNASE3
41spastic diplegia10.1CCL11, IL13, IL5
42sarcoma10.1CSF2, IL4
43disordered steroidogenesis due to cytochrome p450 oxidoreductase10.1CCL11, IL13, IL5
44hydrops of gallbladder10.1CCL5, IL4, IL5
45asthma10.1
46prostate small cell carcinoma10.1IL13, IL5
47hypercementosis10.1CCL5, IL13, IL5
48conjunctival concretion10.1CCL11, IL13, IL5
49smooth muscle tumor10.1CCL5, IL13, IL5
50primary optic atrophy10.1CCL5, CSF2

Comorbidity relations with Pulmonary Eosinophilia via Phenotypic Disease Network (PDN):


BronchitisChronic Myocardial Ischemia
Deficiency AnemiaFamilial Atrial Fibrillation
Heart DiseaseIron Deficiency Anemia
Ischemic Heart DiseasePostinflammatory Pulmonary Fibrosis
Protein-Energy MalnutritionActive Peptic Ulcer Disease
Acute CystitisChronic Kidney Failure
Decubitus UlcerEsophagitis
Respiratory FailureSchizophreniform Disorder

Graphical network of the top 20 diseases related to Pulmonary Eosinophilia:



Diseases related to pulmonary eosinophilia

Symptoms & Phenotypes for Pulmonary Eosinophilia

About this section

MGI Mouse Phenotypes related to Pulmonary Eosinophilia according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053888.4CCL11, CSF2, IL13, IL4, IL5
2MP:00053977.7CCL11, CCL17, CCL5, CSF2, EPX, IL13
3MP:00053877.6CCL11, CCL17, CCL5, CSF2, EPX, IL13

Drugs & Therapeutics for Pulmonary Eosinophilia

About this section

Drugs for Pulmonary Eosinophilia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 108)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
BudesonideapprovedPhase 443251333-22-363006, 5281004
Synonyms:
(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(R,S)-11b,16a,17,21,tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with buty raldehyde
(RS)-(11beta,16alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
(RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
(S)-16alpha,17-(Butylidenedioxy)-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11-,21-dihydroxypregna-1,4-diene-3,20-dione
16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione
16alpha(R),17-(Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
16alpha-,17alpha--butylidenedioxypregna-1,4-diene-11beta-,21-diol-3,20-dione
51333-22-3
AC-4697
AC1L1DQE
AC1L1Y6Y
AC1L22VC
AC1MHWI7
B 7777
B7777_SIGMA
BPBio1_000523
BRD-A34299591-001-03-4
BRD-A82238138-001-01-7
BSPBio_000475
BSPBio_002160
Bidien
Bio-0010
Budecort Inhaler
Budenofalk
Budeson
Budesonide (JAN/USAN/INN)
Budesonide Easyhaler
Budesonide MMX
Budesonide [USAN:INN:BAN:JAN]
Budesonido
Budesonido [INN-Spanish]
Budesonidum
Budesonidum [INN-Latin]
Budiair
Budicort
C25H34O6
CCRIS 5230
CHEBI:3207
CHEBI:656601
CHEMBL1370
CID2462
CID3033890
CID40000
CID5281004
CID63006
CPD000058337
Cortivent
D00246
DB01222
Desowen
Dexbudesonide
Dexbudesonide [INN]
DivK1c_000475
EINECS 257-139-7
EINECS 257-160-1
EINECS 257-161-7
EU-0100174
Entocort
Entocort EC
Entocort EC (TN)
Giona Easyhaler
HMS1569H17
HMS1921I22
HMS2094I13
HMS501H17
Horacort
 
IDI1_000475
Inflammide
KBio1_000475
KBio3_001660
KBioGR_001361
LS-187734
LS-7235
Lopac0_000174
MAP-0010
MLS000028507
MLS001077323
MLS002207112
Micronyl
Miflonide
MolPort-002-529-265
MolPort-003-666-332
MolPort-003-986-909
NCGC00015165-03
NCGC00021318-03
NCGC00021318-06
NCGC00089747-02
NCGC00089747-03
NCGC00089747-04
NCGC00178789-01
NINDS_000475
Noex
Preferid
Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
Prestwick0_000518
Prestwick1_000518
Prestwick2_000518
Prestwick3_000518
Prestwick_840
Pulmaxan
Pulmaxan turbohaler
Pulmicort
Pulmicort (TN)
Pulmicort Flexhaler
Pulmicort Nebuamp
Pulmicort Respules
Pulmicort Topinasal
Pulmicort Turbuhaler
Pulmicort turbuhaler
Respules
Rhinocort
Rhinocort Aqua
Rhinocort Turbuhaler
Rhinocort alpha
Rhinocort, Pulmicort , Entocort, Symbicort, Noex. Entocort EC, Budesonide
Rhinosol
S 1320
S-1320
S1286_Selleck
SAM002699898
SMR000058337
SPBio_000586
SPBio_002396
SPECTRUM1500813
ST51039033
Spectrum2_000623
Spectrum3_000620
Spectrum4_000821
Spectrum5_001738
Spirocort
TL8003397
Tridesilon
UDB
UNII-168L5HT37P
UNII-2HI1006KPH
UNII-Q3OKS62Q6X
Unit dose budesonide
ZINC03938751
ZINC04097286
budesonide
2
Nitric OxideapprovedPhase 4, Phase 261710102-43-9145068
Synonyms:
(.)NO
(NO)(.)
10102-43-9
14332-28-6
295566_ALDRICH
51005-20-0
51005-21-1
53851-19-7
90452-29-2
AC1L1ADQ
AC1L3QHF
AC1Q6QZ0
AR-1K7463
Bioxyde d'azote
Bioxyde d'azote [French]
C00533
CCRIS 4319
CHEMBL1200689
CHEMBL1234765
CID145068
CID945
D00074
D009569
DB00435
EDRF
EINECS 233-271-0
Endogenous Nitrate Vasodilator
Endothelium-Derived Nitric Oxide
HNO
HSDB 1246
INOmax
INOmax (TN)
LS-192158
LS-7547
MolPort-003-929-452
Mononitrogen monoxide
Monoxide, Mononitrogen
Monoxide, Nitrogen
Monoxido de nitrogeno
Monoxyde d'azote
NITRIC-OXIDE
NO
NO(.)
Nitrate Vasodilator, Endogenous
Nitric Oxide, Endothelium Derived
 
Nitric Oxide, Endothelium-Derived
Nitric oxide
Nitric oxide (JAN)
Nitric oxide 10% by volume or more
Nitric oxide trimer
Nitric oxide, compressed [UN1660] [Poison gas]
Nitric oxide, compressed [UN1660] [Poison gas]
Nitrogen monoxide
Nitrogen oxide
Nitrogen oxide (NO)
Nitrogen protoxide
Nitrosyl
Nitrosyl hydride
Nitrosyl hydride ((NO)H)
Nitrosyl radical
Nitroxide radical
Nitroxyl
OHM 11771
Oxide, Nitric
Oxido de nitrogeno(ii)
Oxido nitrico
Oxyde azotique
Oxyde nitrique
Oxyde nitrique [French]
RCRA waste no. P076
Stickmonoxyd
Stickmonoxyd [German]
Stickstoff(II)-oxid
Stickstoff(ii)-oxid
Stickstoffmonoxid
UN 1660
UN1660
UNII-31C4KY9ESH
Vasodilator, Endogenous Nitrate
[NO]
endothelium-derived relaxing factor
monoxido de nitrogeno
monoxyde d'azote
nitric oxide
nitrogen monooxide
nitrogen monoxide
nitrosyl
oxido de nitrogeno(II)
oxido nitrico
oxidonitrogen(.)
oxoazanyl
oxyde azotique
3
Omalizumabapproved, investigationalPhase 4145242138-07-4
Synonyms:
242138-07-4
D05251
Ig gamma-1 chain C region
Omalizumab
 
Omalizumab (USAN/INN)
Omalizumab (genetical recombination)
Omalizumab (genetical recombination) (JAN)
Xolair
Xolair (TN)
4
MontelukastapprovedPhase 4270158966-92-85281040
Synonyms:
(R-(E))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
1-((((1R)-1-(3-((1E)-2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid
151767-02-1 (sodium)
158966-92-8
2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid
AC1NQXXW
Apxi toxin
BIDD:GT0394
Brondilat
Brondilat (TN)
C07482
C35H36ClNO3S
CHEBI:50730
CHEMBL787
CID5281040
 
D08229
DB00471
HMS2089D07
HSDB 7582
LS-173539
MK 0476
MK-0476
Montair
Montelukast
Montelukast (INN)
Montelukast [INN:BAN]
Montelukastum
Montélukast
Singulair
Singular
UNII-MHM278SD3E
montelukast
sodium 1-(((1-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropylacetate
{1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetic acid
5
Ciclesonideapproved, investigationalPhase 474126544-47-6, 141845-82-1444033
Synonyms:
(R)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclohexanecarboxaldehyde, 21-isobutyrate
126544-47-6
141845-82-1
AC-1330
Alvesco
Alvesco (TN)
Alvesco HFA
B-9207-015
BTR-15
BTR-15K
BY-9010
BYK-20426
CID6918155
Ciclesonide
 
Ciclesonide (JAN/USAN/INN)
Ciclesonide [INN]
D01703
KS-1165
LS-186047
MolPort-005-940-705
NCGC00167972-01
Omnair
Omnaris
Omnaris HFA
Osonase
Osonide
RPR 251526
TBN-15
UNII-S59502J185
6
Methylprednisoloneapproved, vet_approvedPhase 4, Phase 3119383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
7
Prednisoloneapproved, vet_approvedPhase 4, Phase 3119350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
8Peripheral Nervous System AgentsPhase 4, Phase 223689
9Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 213168
10ImmunoglobulinsPhase 4, Phase 3, Phase 26394
11Anti-Asthmatic AgentsPhase 4, Phase 23488
12HormonesPhase 4, Phase 3, Phase 214415
13Anti-Allergic AgentsPhase 4, Phase 21522
14Leukotriene AntagonistsPhase 4293
15Autonomic AgentsPhase 4, Phase 210150
16Anti-Inflammatory AgentsPhase 4, Phase 3, Phase 210729
17Respiratory System AgentsPhase 4, Phase 24997
18Antibodies, MonoclonalPhase 4, Phase 3, Phase 24039
19Hormone AntagonistsPhase 4, Phase 3, Phase 213180
20Bronchodilator AgentsPhase 4, Phase 22965
21glucocorticoidsPhase 4, Phase 3, Phase 25103
22AntibodiesPhase 4, Phase 3, Phase 26394
23AlbuterolPhase 4, Phase 2429
24Neurotransmitter AgentsPhase 4, Phase 218340
25Adrenergic AgonistsPhase 4, Phase 23027
26Adrenergic beta-2 Receptor AgonistsPhase 4, Phase 2957
27Adrenergic beta-AgonistsPhase 4, Phase 21714
28Fluticasone Propionate, Salmeterol Xinafoate Drug CombinationPhase 4, Phase 2205
29
FluticasonePhase 4, Phase 264490566-53-3, 80474-14-262924, 22833648
Synonyms:
90566-53-3
AC-456
AC1NSJZT
Asmatil
Axotide
BIDD:GT0819
Brethal
C07815
CHEMBL1201396
CID5311101
Cultivate
Cutivate
D07981
Flixonase
Flixonase Nasal Spray
Flixotide
Flixotide Disk
 
Flixotide Disks
Flixotide Inhaler
Flonase
Flovent
Flovent Diskus
Flovent Rotadisk
Fluinol
Flunase
Flusonal
Fluspiral
Fluticaps
Fluticaps (TN)
Fluticasone (INN)
Fluticasonpropionat Allen
Flutide
Flutivate
MolPort-006-666-449
S-(fluoromethyl) (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate
fluticasone
30Adrenergic AgentsPhase 4, Phase 25352
31Dermatologic AgentsPhase 4, Phase 25806
32
Salmeterol xinafoatePhase 4, Phase 235994749-08-356801
Synonyms:
(+-)-4-Hydroxy-alpha(sup 1)-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-m-xylene-alpha,alpha'-diol 1-hydroxy-2-naphthoate (salt)
(+/-) 4-Hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]m-ethyl]-1,3-benzenedimethanol xinafoate
1,3-Benzenedimethanol, 4-hydroxy-alpha(sup 1)-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-, (+-)-, 1-hydroxy-2-naphthalenecarboxylate (salt)
1-hydroxynaphthalene-2-carboxylic acid
2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol
89365-50-4 (Parent)
94749-08-3
AC1L1LPS
Arial
Asmerole
Beglan
Betamican
Bio-0096
C25H37NO4.C11H8O3
CHEMBL1082607
CID56801
D00687
Dilamax
EU-0101100
GR 33343 G
GR 33343X xinafoate
 
GR-33343 G
Inaspir
LS-94516
MLS001332577
MLS001332578
MolPort-003-850-218
NCGC00094372-01
NCGC00094372-02
NCGC00094372-03
NCGC00094372-04
S5068_SIGMA
SMR000875207
Salmetedur
Salmeterol 1-hydroxy-2-naphthoate
Salmeterol xinafoate (JAN/USAN)
Salmeterol xinafoate [USAN]
Serevent (TN)
Serevent Inhaler and Disks
Serevent diskus
UNII-6EW8Q962A5
Ultrabeta
salmeterol xinafoate
33AntioxidantsPhase 4, Phase 2, Phase 13050
34Tocolytic AgentsPhase 4, Phase 2739
35Neuroprotective AgentsPhase 41716
36AntiemeticsPhase 44022
37Methylprednisolone HemisuccinatePhase 4, Phase 31193
38Methylprednisolone acetatePhase 4, Phase 31193
39Gastrointestinal AgentsPhase 48402
40Prednisolone acetatePhase 4, Phase 31193
41Prednisolone hemisuccinatePhase 4, Phase 31193
42Immunoglobulin EPhase 436
43Protective AgentsPhase 4, Phase 2, Phase 17443
44Prednisolone phosphatePhase 4, Phase 31193
45Antineoplastic Agents, HormonalPhase 4, Phase 3, Phase 25592
46Fluorodeoxyglucose F18Phase 4412
47RadiopharmaceuticalsPhase 4514
48Muscarinic AntagonistsPhase 41166
49Vasodilator AgentsPhase 43543
50ParasympatholyticsPhase 41085

Interventional clinical trials:

(show top 50)    (show all 67)
idNameStatusNCT IDPhase
1Effect of Xolair on Airway HyperresponsivenessUnknown statusNCT00208234Phase 4
2Efficacy and Safety of add-on Montelukast to Inhaled Budesonide in the Treatment of Nonasthmatic Eosinophilic BronchitisUnknown statusNCT01121016Phase 4
3The Efficacy of Three Months-prednisolone Therapy for Chronic Eosinophilic PneumoniaCompletedNCT00632554Phase 4
4Small Particle Steroids in Refractory AsthmaCompletedNCT01171365Phase 4
5Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonistsCompletedNCT00670930Phase 4
6An Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway InflammationRecruitingNCT02937168Phase 4
7The RECONSTRUCT Study - Reconstructing Disease Mechanisms in AsthmaRecruitingNCT03034005Phase 4
8Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma PatientsActive, not recruitingNCT02654145Phase 4
9Exhaled NO Based Treatment of Chronic Obstructive Pulmonary Disease (COPD), ICS/LABA Versus LAMAActive, not recruitingNCT02546349Phase 4
10Mepolizumab Treatment for Rhinovirus-induced Asthma ExacerbationsUnknown statusNCT01520051Phase 3
11A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic AsthmaCompletedNCT01285323Phase 3
12A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic AsthmaCompletedNCT01270464Phase 3
13A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic AsthmaCompletedNCT01287039Phase 3
14Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma ControlCompletedNCT02281318Phase 3
15Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe AsthmaCompletedNCT01508936Phase 3
16Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)CompletedNCT00647166Phase 3
17Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma PatientsRecruitingNCT02555371Phase 3
18A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic AsthmaRecruitingNCT03052725Phase 3
19Study of Mepolizumab Autoinjector in AsthmaticsRecruitingNCT03099096Phase 3
20Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)RecruitingNCT02836496Phase 3
21Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.RecruitingNCT02563067Phase 3
22Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.RecruitingNCT02555683Phase 3
23Effects of Mepolizumab Compared to Placebo on Airway Physiology in Patients With Eosinophilic Asthma: MEMORY StudyActive, not recruitingNCT02594332Phase 3
24Study of Mepolizumab Safety Syringe in AsthmaticsActive, not recruitingNCT03021304Phase 3
25A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic SubjectsActive, not recruitingNCT02135692Phase 3
26Anti-Interleukin-5 (IL5) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic AsthmaEnrolling by invitationNCT02559791Phase 2, Phase 3
27Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic AsthmaTerminatedNCT01290887Phase 3
28A Phase IIa Study of KHK4563CompletedNCT01412736Phase 2
29Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic AsthmaCompletedNCT01312961Phase 2
30A Study to Evaluate the Effectiveness of MEDI-563 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01227278Phase 2
31Anti-Interleukin-5 Antibody to Treat Hypereosinophilic SyndromeCompletedNCT00017862Phase 2
32Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)CompletedNCT00086658Phase 2
33OC000459 Bronchial Allergen ChallengeCompletedNCT01056692Phase 2
34Safety and Efficacy Study of OC000459 Dosed Twice Daily for 28 Days in Asthmatic SubjectsCompletedNCT01057927Phase 2
35Safety and Efficacy of QAW039 in Sputum Eosinophilia and Persistent AsthmaCompletedNCT01545726Phase 2
36Oral GW766944 (Oral CCR3 Antagonist)CompletedNCT01160224Phase 2
37The Prednisone-sparing Effect of Anti-IL-5 Antibody (SB-240563)CompletedNCT00292877Phase 2
38A Phase IIa Study of Subcutaneous AER 001 on Antigen Challenge In Atopic Asthmatic Subjects (28 Day Study)CompletedNCT00535028Phase 2
39Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase EnzymesCompletedNCT00171912Phase 2
40Effect of OC000459 on Eosinophilic Airway Inflammation in Severe AsthmaRecruitingNCT02560610Phase 2
41Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic SyndromeRecruitingNCT02130882Phase 2
42Effect of OC459 on the Response to Rhinovirus Challenge in AsthmaRecruitingNCT02660489Phase 2
43Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in ChildrenActive, not recruitingNCT02377427Phase 2
44Investigation of Lung Ventilation Inhomogeneity in Pediatric AsthmaActive, not recruitingNCT01095354Phase 2
45Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic SyndromeActive, not recruitingNCT02101138Phase 2
46Effect of House Dust Mite Allergen Challenge in Persons Using 1200 mg Gamma Tocopherol SupplementsCompletedNCT00466596Phase 1
47Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyCompletedNCT00890747Phase 1
48Allogeneic Human Cells (hMSC) Via Intravenous Delivery in Patients With Mild AsthmaRecruitingNCT03137199Phase 1
49Sirolimus for Eosinophil-Associated Gastrointestinal DisordersTerminatedNCT01814059Phase 1
50Usefulness of Exhaled NO in the Differential Diagnosis Acute Eosinophilic Pneumonia and Bacterial PneumoniaUnknown statusNCT01152424

Search NIH Clinical Center for Pulmonary Eosinophilia

Genetic Tests for Pulmonary Eosinophilia

About this section

Anatomical Context for Pulmonary Eosinophilia

About this section

MalaCards organs/tissues related to Pulmonary Eosinophilia:

36
Lung, T cells, Testes, Bone, Breast, Bone marrow, Heart

Publications for Pulmonary Eosinophilia

About this section

Articles related to Pulmonary Eosinophilia:

(show top 50)    (show all 288)
idTitleAuthorsYear
1
Pulmonary Eosinophilia From Inhaled Colistin. (28065254)
2017
2
Concurrent sensitization to Aspergillus Fumigatus in tropical pulmonary eosinophilia. (27374215)
2016
3
Pulmonary eosinophilia associated to treatment with natalizumab. (27512514)
2016
4
Acetaminophen Use: An Unusual Cause of Drug-Induced Pulmonary Eosinophilia. (27445539)
2016
5
A rare presentation of hydropneumothorax in tropical pulmonary eosinophilia: cavitation and pneumonic consolidation in a child. (26376823)
2015
6
An Unusual Case of Foreign Body Aspiration Masquerading as Pulmonary Eosinophilia. (26266154)
2015
7
Natural helper cells contribute to pulmonary eosinophilia by producing IL-13 via IL-33/ST2 pathway in a murine model of respiratory syncytial virus infection. (26044350)
2015
8
Host lung immunity is severely compromised during tropical pulmonary eosinophilia: role of lung eosinophils and macrophages. (26489428)
2015
9
Simple pulmonary eosinophilia associated with clozapine treatment. (25514065)
2015
10
Simple pulmonary eosinophilia found on follow-up computed tomography of oncologic patients. (25082475)
2014
11
Pulmonary eosinophilia caused by testosterone cypionate. (23998379)
2013
12
A rare case of ethambutol induced pulmonary eosinophilia. (24250213)
2013
13
Regulatory T cells prevent Th2 immune responses and pulmonary eosinophilia during respiratory syncytial virus infection in mice. (23926350)
2013
14
Tropical pulmonary eosinophilia--a review. (24135173)
2013
15
Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. (22331917)
2012
16
Interleukin-17 drives pulmonary eosinophilia following repeated exposure to Aspergillus fumigatus conidia. (22252873)
2012
17
FICZ, a tryptophan photoproduct, suppresses pulmonary eosinophilia and Th2-type cytokine production in a mouse model of ovalbumin-induced allergic asthma. (22561122)
2012
18
Tropical pulmonary eosinophilia misdiagnosed as miliary tuberculosis: a case report and literature review. (22172479)
2012
19
Regulator of calcineurin 1 (Rcan1) is required for the development of pulmonary eosinophilia in allergic inflammation in mice. (21741935)
2011
20
Acquired alpha 1-antitrypsin deficiency in tropical pulmonary eosinophilia. (21808138)
2011
21
A mouse model of airway disease: oncostatin M-induced pulmonary eosinophilia, goblet cell hyperplasia, and airway hyperresponsiveness are STAT6 dependent, and interstitial pulmonary fibrosis is STAT6 independent. (21160052)
2011
22
Role of oxidants in interstitial lung diseases: pneumoconioses, constrictive bronchiolitis, and chronic tropical pulmonary eosinophilia. (22131646)
2011
23
Chlorogenic acid suppresses pulmonary eosinophilia, IgE production, and Th2-type cytokine production in an ovalbumin-induced allergic asthma: activation of STAT-6 and JNK is inhibited by chlorogenic acid. (20637839)
2010
24
Levels of circulating IL-33 and eosinophil cationic protein in patients with hypereosinophilia or pulmonary eosinophilia. (20719375)
2010
25
Serum C3d levels in tropical pulmonary eosinophilia. (20424307)
2010
26
Oral tolerance inhibits pulmonary eosinophilia in a cockroach allergen induced model of asthma: a randomized laboratory study. (21092270)
2010
27
Enhancement of ovalbumin-induced pulmonary eosinophilia by intranasal administration of alpha1-proteinase inhibitor type 2 antisense oligonucleotides. (19111575)
2009
28
Pulmonary eosinophilia. (19618037)
2009
29
Pulmonary eosinophilia is attenuated by early responding CD8(+) memory T cells in a murine model of RSV vaccine-enhanced disease. (19594395)
2009
30
Clinical alterations and mRNA levels of IL-4 and IL-5 in bronchoalveolar cells of horses with transient pulmonary eosinophilia. (17996260)
2008
31
Pulmonary eosinophilia correlates with allergen deposition to the lower respiratory tract in a mouse model of asthma. (18537985)
2008
32
Transient pulmonary eosinophilia incidentally found on low-dose computed tomography: findings in 40 individuals. (18303297)
2008
33
Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein. (18519743)
2008
34
Pulmonary eosinophilia. (18197481)
2008
35
The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia. (19017987)
2008
36
The JAK-3 inhibitor CP-690550 is a potent anti-inflammatory agent in a murine model of pulmonary eosinophilia. (18242596)
2008
37
Tropical pulmonary eosinophilia in a patient undergoing open heart surgery. (18285744)
2008
38
Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virus. (18094193)
2008
39
A carbohydrate fraction, AIP1 from Artemisia iwayomogi suppresses pulmonary eosinophilia and Th2-type cytokine production in an ovalbumin-induced allergic asthma. Down-regulation of TNF-alpha expression in the lung. (18068107)
2008
40
Tropical pulmonary eosinophilia: pathogenesis, diagnosis and management. (17940489)
2007
41
C5 modulates airway hyperreactivity and pulmonary eosinophilia during enhanced respiratory syncytial virus disease by decreasing C3a receptor expression. (17079327)
2007
42
A critical role for Pin1 in allergic pulmonary eosinophilia in rats. (17720236)
2007
43
Eosinophilic pustular folliculitis associated with pulmonary eosinophilia. (17714146)
2007
44
Tropical pulmonary eosinophilia: a rare cause of cough in immigrants to Australia. (17908009)
2007
45
Elevated levels of fragmented laminin-5 gamma2-chain in bronchoalveolar lavage fluid from dogs with pulmonary eosinophilia. (16624727)
2006
46
Death receptor-6 regulates the development of pulmonary eosinophilia and airway inflammation in a mouse model of asthma. (16730379)
2006
47
Parasitic pulmonary eosinophilia. (16612768)
2006
48
Simple pulmonary eosinophilia evaluated by means of FDG PET: the findings of 14 cases. (16374077)
2005
49
Tropical pulmonary eosinophilia. (15712096)
2005
50
A rho kinase inhibitor, Y-27632 inhibits pulmonary eosinophilia, bronchoconstriction and airways hyperresponsiveness in allergic mice. (15607129)
2005

Variations for Pulmonary Eosinophilia

About this section

Expression for genes affiliated with Pulmonary Eosinophilia

About this section
Search GEO for disease gene expression data for Pulmonary Eosinophilia.

Pathways for genes affiliated with Pulmonary Eosinophilia

About this section

Pathways related to Pulmonary Eosinophilia according to GeneCards Suite gene sharing:

(show all 32)
idSuper pathwaysScoreTop Affiliating Genes
19.8IL4, IL5
29.4IL13, IL4, IL5
39.4IL13, IL4, IL5
4
Show member pathways
9.4IL13, IL4, IL5
59.4IL13, IL4, IL5
69.4IL13, IL4, IL5
79.3CCL11, IL13, IL4
89.2CSF2, IL4, IL5
9
Show member pathways
9.2CSF2, IL4, IL5
109.2CSF2, IL4, IL5
11
Show member pathways
9.2CSF2, IL4, IL5
128.9CCL11, CCL17, IL4, IL5
13
Show member pathways
8.9CCL11, CCL5, CCL7
14
Show member pathways
8.8CSF2, IL13, IL4, IL5
15
Show member pathways
8.8CSF2, IL13, IL4, IL5
168.8CSF2, IL13, IL4, IL5
178.8CSF2, IL13, IL4, IL5
188.6CCL5, CSF2, IL13, IL4
198.5CCL11, CCL17, IL13, IL4, IL5
20
Show member pathways
8.3CCL11, CCL17, CCL5, CCL7
21
Show member pathways
8.3CCL11, CCL17, CCL5, CCL7
22
Show member pathways
8.2CCL11, EPX, IL13, IL4, IL5, RNASE3
23
Show member pathways
8.0CCL11, CCL5, CSF2, IL13, IL4, IL5
248.0CCL11, CCL5, CSF2, IL13, IL4, IL5
25
Show member pathways
7.2CCL11, CCL17, CCL5, CCL7, IL13, IL4
26
Show member pathways
7.1CCL11, CCL5, CSF2, EPX, IL13, IL4
27
Show member pathways
7.1CCL11, CCL17, CCL7, CSF2, IL13, IL4
28
Show member pathways
6.6CCL11, CCL17, CCL5, CCL7, CSF2, IL13
29
Show member pathways
6.6CCL11, CCL17, CCL5, CCL7, CSF2, IL13
30
Show member pathways
6.6CCL11, CCL17, CCL5, CCL7, CSF2, IL13
31
Show member pathways
6.6CCL11, CCL17, CCL5, CCL7, CSF2, IL13
326.6CCL11, CCL17, CCL5, CCL7, CSF2, IL13

GO Terms for genes affiliated with Pulmonary Eosinophilia

About this section

Cellular components related to Pulmonary Eosinophilia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular regionGO:00055766.5CCL11, CCL17, CCL5, CCL7, CSF2, EPX
2extracellular spaceGO:00056155.8CCL11, CCL17, CCL5, CCL7, CSF2, EPX

Biological processes related to Pulmonary Eosinophilia according to GeneCards Suite gene sharing:

(show all 31)
idNameGO IDScoreTop Affiliating Genes
1innate immune response in mucosaGO:000222710.5IL4, RNASE3
2microglial cell activationGO:000177410.4IL13, IL4
3negative regulation of complement-dependent cytotoxicityGO:190366010.4IL13, IL4
4negative regulation of endothelial cell apoptotic processGO:200035210.4IL13, IL4
5lymphocyte chemotaxisGO:004824710.3CCL11, CCL17
6positive regulation of JAK-STAT cascadeGO:004642710.2CCL5, IL5
7positive regulation of immunoglobulin productionGO:000263910.2IL13, IL4
8dendritic cell differentiationGO:009702810.2CSF2, IL4
9positive regulation of mast cell degranulationGO:004330610.2IL13, IL4
10myeloid dendritic cell differentiationGO:004301110.2CSF2, IL4
11positive regulation of B cell proliferationGO:003089010.1IL13, IL4, IL5
12positive regulation of podosome assemblyGO:007180310.0CSF2, IL5
13positive regulation of natural killer cell chemotaxisGO:20005039.7CCL5, CCL7
14regulation of proton transportGO:00101559.7IL13, IL4
15cellular calcium ion homeostasisGO:00068749.6CCL11, CCL5, CCL7
16eosinophil chemotaxisGO:00482459.6CCL11, CCL5, CCL7
17positive regulation of tyrosine phosphorylation of Stat5 proteinGO:00425239.5CSF2, IL4
18positive regulation of cell migrationGO:00303359.5CCL11, CCL5, CCL7
19positive regulation of tyrosine phosphorylation of STAT proteinGO:00425319.4CCL5, CSF2, IL4
20cellular response to interferon-gammaGO:00713469.1CCL11, CCL17, CCL5, CCL7
21cellular response to interleukin-1GO:00713479.1CCL11, CCL17, CCL5, CCL7
22cellular response to tumor necrosis factorGO:00713569.1CCL11, CCL17, CCL5, CCL7
23chemokine-mediated signaling pathwayGO:00700989.1CCL11, CCL17, CCL5, CCL7
24monocyte chemotaxisGO:00025489.0CCL11, CCL17, CCL5, CCL7
25neutrophil chemotaxisGO:00305939.0CCL11, CCL17, CCL5, CCL7
26cell-cell signalingGO:00072679.0CCL17, CCL5, CCL7, IL13
27positive regulation of ERK1 and ERK2 cascadeGO:00703749.0CCL11, CCL17, CCL5, CCL7
28chemotaxisGO:00069358.7CCL11, CCL17, CCL5, CCL7, IL4
29inflammatory responseGO:00069548.3CCL11, CCL17, CCL5, CCL7, IL13, IL5
30positive regulation of GTPase activityGO:00435478.0CCL11, CCL17, CCL5, CCL7, CSF2, IL5
31immune responseGO:00069557.4CCL11, CCL17, CCL5, CCL7, CSF2, IL13

Molecular functions related to Pulmonary Eosinophilia according to GeneCards Suite gene sharing:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1cytokine receptor bindingGO:000512610.3IL13, IL4
2CCR chemokine receptor bindingGO:004802010.3CCL11, CCL17
3CCR4 chemokine receptor bindingGO:003172910.1CCL17, CCL5
4CCR1 chemokine receptor bindingGO:00317269.8CCL5, CCL7
5growth factor activityGO:00080839.2CSF2, IL4, IL5
6chemokine activityGO:00080099.0CCL11, CCL17, CCL5, CCL7
7cytokine activityGO:00051257.2CCL11, CCL17, CCL5, CCL7, CSF2, IL13

Sources for Pulmonary Eosinophilia

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet